UPDATED May 03, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GWIND | ₺29.46 | 4.5% | 109.5% | ₺15.9b | ₺39.79 | PE25.5x | E60.9% | 3.1% | Utilities | ||
OSE | €6.20 | 11.5% | 63.4% | €133.7m | €7.15 | PS60x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
CALTX | kr106.60 | 2.8% | -16.8% | kr5.7b | kr208.00 | PS4.7x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$23.29 | 1.4% | 240.0% | CA$799.9m | CA$24.61 | PE21x | E33.8% | 2.0% | Diversified Financials | ||
ZVRA | US$4.81 | 6.4% | -2.0% | US$198.8m | US$19.00 | PS7.3x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
GIG | kr33.70 | 2.7% | 19.5% | kr4.4b | kr49.14 | PE27.8x | E40.7% | n/a | Consumer Services | ||
RDUE | €9.65 | 1.6% | 4.9% | €60.3m | €10.50 | PE17.8x | E37.7% | n/a | Capital Goods | ||
ALNY | US$152.33 | 6.3% | -28.2% | US$19.0b | US$221.12 | PS9.6x | E60.5% | n/a | Pharmaceuticals & Biotech | ||
AESI | US$21.97 | -6.2% | 29.2% | US$2.4b | US$25.90 | PE22.9x | E44.7% | 3.6% | Energy | ||
ELF | US$160.12 | -10.9% | 81.2% | US$8.9b | US$205.92 | PE68.7x | E26.4% | n/a | Household | ||
FDE | €34.00 | 0.9% | -4.0% | €177.8m | €64.07 | PE22.6x | E37.6% | n/a | Energy | ||
NEWBRY | kr3.23 | -5.3% | -42.7% | kr78.4m | kr8.00 | PS3.4x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | kr1.50 | -7.4% | 39.3% | kr407.3m | kr1.80 | PS4.5x | E98.1% | n/a | Tech | ||
RCEL | US$8.75 | 2.7% | -46.5% | US$225.0m | US$25.90 | PS4.5x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
AGP | €8.32 | 8.9% | 137.7% | €144.0m | €12.75 | PE29.3x | E22.8% | n/a | Capital Goods | ||
MVW | kr8.20 | -6.3% | 5.7% | kr268.3m | kr13.00 | PS24.4x | E66.8% | n/a | Materials | ||
APLT | US$4.76 | 11.2% | 201.3% | US$517.5m | US$11.60 | PS54.4x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$16.19 | 20.2% | -52.8% | US$2.4b | US$31.50 | PE56.9x | E46.2% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €8.47 | 0.5% | 164.7% | €121.0m | €9.70 | PS20x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
AVLL3 | R$3.80 | 5.3% | 35.2% | R$730.5m | R$9.90 | PS1.6x | E101.9% | n/a | Consumer Durables | ||
ARES | US$131.91 | -1.3% | 61.0% | US$41.7b | US$146.60 | PE59.4x | E41.7% | 2.8% | Diversified Financials | ||
FWRY | ج.م5.93 | -2.8% | 2.2% | ج.م20.2b | ج.م7.20 | PE32.7x | E34.8% | n/a | Diversified Financials | ||
ATAKP | ₺47.18 | -0.8% | n/a | ₺6.5b | ₺67.66 | PE22.1x | E72.8% | n/a | Food, Beverage & Tobacco | ||
NVDA | US$887.89 | 1.2% | 209.6% | US$2.2t | US$1,002.20 | PE73.4x | E23.4% | 0.02% | Semiconductors |